US$ 27.20
teva pharmaceuticals introduces the first generic glp-1 for weight loss Launches First-Ever GLP-1: A Game-Changer Diabetes and Management The FDA has approved the
Description
[DOI] [PMC free article] [PubMed] [Google Scholar] 24.Mody R., Huang Q., Yu M., Zhao R., Patel H., Grabner M., Land L.F
Stanton R

Given the significant clinical and methodological variation among the included trials, this substantial heterogeneity is not surprising
But that raises a deeper question: What, exactly, are we changing
More approved uses may come

doi: 10.1016/j.ekir.2019.12.011
